Kiora Pharmaceuticals (KPRX) Institutional Ownership $3.27 +0.03 (+0.93%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Kiora Pharmaceuticals (NASDAQ:KPRX)CurrentInstitutional OwnershipPercentage76.97%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$15.45MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$24.27M Get KPRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Kiora Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data KPRX Institutional Buying and Selling by Quarter Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Kiora Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/21/2024 Stonepine Capital Management LLC200,000$840K0.8%N/A6.856% 8/20/2024 Nantahala Capital Management LLC211,110$887K0.1%-88.9%7.237% 8/7/2024 AIGH Capital Management LLC255,561$1.07M0.3%-88.9%8.761% 7/12/2024 Rosalind Advisors Inc.255,555$1.07M0.8%-88.9%8.752% 4/25/2024 Rosalind Advisors Inc.2,300,000$1.62M1.5%N/A8.759% (Data available from 1/1/2016 forward) KPRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of KPRX shares? During the previous two years, the following institutional investors and hedge funds held shares of Kiora Pharmaceuticals shares: AIGH Capital Management LLC ($1.07M), Rosalind Advisors Inc. ($1.07M), and Nantahala Capital Management LLC ($887K), Stonepine Capital Management LLC ($840K).Learn more on KPRX's institutional investors. What percentage of Kiora Pharmaceuticals stock is owned by institutional investors? 76.97% of Kiora Pharmaceuticals stock is owned by institutional investors. Learn more on KPRX's institutional investor holdings. Which institutional investors have been buying Kiora Pharmaceuticals stock? The following institutional investors have purchased Kiora Pharmaceuticals stock in the last 24 months: Rosalind Advisors Inc. ($2.30M), and Stonepine Capital Management LLC ($200K). How much institutional buying is happening at Kiora Pharmaceuticals? Institutional investors have bought a total of 2,500,000 shares in the last 24 months. This purchase volume represents approximately $15.45M in transactions. Which Kiora Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Kiora Pharmaceuticals stock in the last 24 months: Rosalind Advisors Inc. ($2.04M), AIGH Capital Management LLC ($2.04M), and Nantahala Capital Management LLC ($1.69M). How much institutional selling is happening at Kiora Pharmaceuticals? Institutional investors have sold a total of 5,777,774 shares in the last 24 months. This volume of shares sold represents approximately $24.27M in transactions. Related Companies Achilles Therapeutics Institutional Ownership OncoCyte Institutional Ownership VYNE Therapeutics Institutional Ownership OS Therapies Institutional Ownership Tempest Therapeutics Institutional Ownership Elevation Oncology Institutional Ownership CalciMedica Institutional Ownership Clene Institutional Ownership RAPT Therapeutics Institutional Ownership Anebulo Pharmaceuticals Institutional Ownership This page (NASDAQ:KPRX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiora Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kiora Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KPRX Stock Alerts